KRISTEN CAPERNA: Open Payments
NPI 1033174438 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 34 payments from 10 companies in 2025. Trend: 2023 $982 · 2024 $948 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $244 |
| Novo Nordisk Inc | 6 | $220 |
| SCPHARMACEUTICALS INC. | 5 | $161 |
| Kestra Medical Technology Services, Inc. | 3 | $158 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $63 |
| PFIZER INC. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $55 |
| Philips North America LLC | 2 | $46 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: Wegovy, FUROSCIX, Assure WCD, CAMZYOS, JARDIANCE, Kerendia, Ambulatory Monitoring & Diagnostics Undivided, VYNDAQEL.
Industry payments across MD — which companies pay providers there.
